Biocon Limited has informed the Exchange regarding a press release dated October 04, 2021, titled "Biocon expands its Generic Formulations portfolio with the launch of Everolimus tablets in the US.".
Biocon Limited has informed the Exchange regarding a press release dated October 04, 2021, titled "Biocon expands its Generic Formulations portfolio with the launch of Everolimus tablets in the US.".